Latest Mergers And Acquisitions News

Page 361 of 1016
ParagonCare has released its audited FY25 financial results, confirming steady profit while revealing a significant reclassification of debt and ongoing challenges with a major retail pharmacy receivable.
Ada Torres
Ada Torres
30 Sept 2025
Myer Holdings has clarified that its FY2025 earnings aligned with market forecasts, addressing concerns following a sharp share price drop after its results announcement.
Logan Eniac
Logan Eniac
30 Sept 2025
Linius Technologies has released its audited FY2025 financial statements, revealing non-cash accounting adjustments related to Convertible Notes that increased reported losses and liabilities compared to prior unaudited figures.
Sophie Babbage
Sophie Babbage
30 Sept 2025
Ryzon Materials has expanded its engineering contract with Xinhai to fast track production at its Nachu Graphite Project, alongside a $500,000 capital raising from Xinhai. The deal involves a $3.5 million contract largely settled through shares and options, pending shareholder approval.
Maxwell Dee
Maxwell Dee
30 Sept 2025
Peak Rare Earths has officially been acquired by Shenghe Resources, with shareholders paid $0.443 per share and delisting from the ASX imminent. This marks a significant consolidation in the rare earths sector.
Maxwell Dee
Maxwell Dee
30 Sept 2025
Uscom Limited has struck a deal to sell its entire business to Singapore-based AXO Medtech VCC for $2.59 million, aiming to unlock capital for growth under new ownership. Shareholder approval is the next critical step before the transaction can proceed.
Ada Torres
Ada Torres
30 Sept 2025
Invex Therapeutics Ltd has had its trading suspension lifted following the announcement of a material acquisition, signaling a pivotal moment for the biotech company.
Ada Torres
Ada Torres
30 Sept 2025
Invex Therapeutics reveals the collapse of confidential acquisition negotiations following shareholder unrest and potential board changes, clarifying recent unusual trading activity.
Ada Torres
Ada Torres
30 Sept 2025
Invex Therapeutics has discontinued exclusive negotiations to acquire a rare neurological disease company due to board instability triggered by a shareholder requisition notice. Despite this setback, the company remains committed to diversifying its neurological treatment portfolio.
Ada Torres
Ada Torres
30 Sept 2025
Spirit Technology Solutions forecasts strong FY26 growth with revenue surpassing $114 million and underlying EBITDA rising between 14% and 23%. The company signals ongoing expansion through organic and potential inorganic avenues.
Sophie Babbage
Sophie Babbage
30 Sept 2025
Washington H. Soul Pattinson and Brickworks Limited have completed their long-anticipated merger, unveiling standalone FY25 results that highlight robust revenue growth and a significant profit turnaround. The combined entity, trading under the Soul Patts ticker SOL, is poised for diversified growth across property, building products, and investment portfolios.
Victor Sage
Victor Sage
30 Sept 2025
Lode Resources has reported promising early exploration results at its Montezuma Silver & Antimony Project in Tasmania, revealing high-grade assays and expanding its land holdings in a critical minerals hotspot.
Maxwell Dee
Maxwell Dee
30 Sept 2025